.webp&w=384&q=75){kind=logo}
Loading, please wait...
Loading, please wait...
Recent advancements in neurophysiology have highlighted the importance of focal brain stimulation dynamics in understanding how localized perturbations influence global brain states. A landmark study by Kabir A et al. utilized concurrent transcranial magnetic stimulation (TMS) and electroencephalography (EEG) to bridge the gap between local neural circuits and large-scale network integration. By employing microstate analysis, researchers captured brain activity transitions at a millisecond resolution, offering a far more nuanced view than traditional trial-averaged responses.
The study focused on two primary targets: the dorsolateral prefrontal cortex (DLPFC) and the primary motor cortex (M1). These regions serve as critical nodes in the frontoparietal and motor networks, respectively. Interestingly, the results demonstrated that stimulation induces highly region-specific effects. For instance, DLPFC stimulation significantly increased the occurrence and transitions of Microstates D and E. At the same time, it suppressed Microstates A and B. In contrast, M1 stimulation primarily increased the occurrence of Microstate A while reducing Microstate B. Consequently, these findings suggest that the functional role of a brain region dictates how stimulation reconfigures the global neural landscape.
Furthermore, the data suggests that post-pulse microstate dynamics differ significantly from baseline after DLPFC stimulation compared to M1. This distinction is vital for clinicians specializing in psychiatry and neurology. Many neuropsychiatric disorders are characterized by disruptions in specific microstates. For example, abnormalities in Microstate D are often linked to schizophrenia and mood disorders. By understanding focal brain stimulation dynamics, practitioners can potentially design personalized neuromodulation protocols that target specific network imbalances, moving away from a \"one-size-fits-all\" approach.
Moreover, the robustness of these results was validated across repeated sessions and independent datasets. This reliability is essential for developing biomarkers that can predict treatment responses. As we move toward more precise neuropsychiatric interventions, the ability to induce specific shifts in global brain states via focal stimulation offers a mechanistic foundation for the next generation of therapeutic strategies. Ultimately, this research provides a roadmap for harnessing site-specific effects to treat complex brain disorders more effectively.
EEG microstates are brief, stable patterns of electrical activity on the scalp that reflect the coordinated activation of large-scale neural networks. They are often called the \"atoms of thought\" because they represent the basic building blocks of human cognition and global brain states.
Stimulation of the DLPFC reconfigures networks associated with higher-order executive functions (Microstates D and E), while M1 stimulation specifically impacts motor-related network dynamics (Microstate A). This confirms that TMS effects are not just local but propagate according to the targeted region's functional connectivity.
Yes. Since many mood disorders involve specific microstate abnormalities, clinicians can use these findings to optimize TMS parameters. By targeting the DLPFC to increase specific microstates, they may achieve better clinical outcomes in treatment-resistant depression.
Disclaimer: This content is for informational and educational purposes only and does not constitute medical advice or a professional relationship. Always seek the advice of a physician or other qualified health provider with any questions regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References
Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.
Open your smartphone camera to scan and install.
A study reveals how focal TMS to the DLPFC and M1 uniquely reconfigures global brain states, providing a roadmap for personalized neuromodulation therapies....
6 months ago
A nationwide study reveals stable pathogen specification rates in infectious diarrhea hospitalizations from 2016 to 2023, accompanied by a marked decline in Clostridioides difficile cases, emphasizing the need for targeted diagnostic stewardship and thoughtful multiplex testing in hospital medicine.
3 days back
A real-world cohort study evaluates anti-Müllerian hormone recovery and fertility outcomes in high-risk GTN patients treated with EMA/CO versus FAEV chemotherapy, demonstrating robust ovarian reserve recovery by six months post-treatment.
4 days back
A real-world Japanese claims database analysis reveals that the 2021 heart failure guideline update drove significant improvements in guideline-directed medical therapy (GDMT). The study highlighted substantial increases in the prescription of sacubitril/valsartan and dapagliflozin among heart failure patients.
4 days back
A multicenter prospective cohort study reveals that 54.1% of patients achieve clinically meaningful neuropathic pain relief after surgery for degenerative cervical myelopathy, driving substantial gains in motor function, mental health, and quality of life.
4 days back
The ferroptosis-immunity axis represents a critical driver of diabetic kidney disease progression. This review explores iron-dependent lipid peroxidation, innate immune cross-talk, emerging candidate biomarkers, and promising targeted therapies to delay renal decline alongside standard glycemic control.
4 days back
